Biovantix Biotechnology, Inc

CIK 2092174 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biovantix Biotechnology, Inc.

Recent SEC filings

FiledFormAccession number
Oct 17, 2025D0001683168-25-007628
Oct 17, 2025D0001683168-25-007630